Dr. Linda Brubaker This is Me

Education

 View all 211 references Web References

1. 1. Key Biographies | NAFC.org

   www.nafc.org/media/media-kit/k - [Cached]

   Published on: 5/26/2008   Last Visited: 5/26/2008

   Linda Brubaker, MD
   
   Dr. Linda Brubaker is an expert in the field of female bladder control and pelvic organ prolapse.She completed her OBGYN residency at the Rush Presbyterian St. Luke's Medical Center in Chicago, and received her M.D. in 1984.She is board certified in Obstetrics and Gynecology.She is a Fellow of the American College of Surgeons and a Fellow of American College of Obstetricians and Gynecological Surgeons.Dr. Brubaker has written more than 90 peer-reviewed articles and numerous book chapters focused on female pelvic medicine and urology.Her articles have been published in journals such as the Journal of Urology, Obstetrics and Gynecology, and the International Urogynecology Journal.She also is a reviewer for many journals like the American Journal of Urology and the Journal of Pelvic Medicine and Surgery.Currently Dr. Brubaker has a clinical office at Loyola University Medical center that specializes in female pelvic medicine, reconstructive surgery and urology.She is also an Assistant Dean at Loyola University Medical Center, and a professor and director of the Division of Female Pelvic Medicine and Reconstructive Surgery in the Department of Obstetrics and Gynecology and Urology at Loyola University Medical Center.

2. 2. www.urologytimes.com

   www.urologytimes.com/urologyti - [Cached]

   Published on: 2/1/2008   Last Visited: 2/14/2008

   Dr. Brubaker
   ...
   using validated measures," said Linda Brubaker, MD, professor of obstetrics/gynecology and urology at Loyola University Medical Center."The duration of efficacy is important to understand in terms of finding out the role of repeat injections and cost effectiveness of a single injection."
   
   Dr. Brubaker reported results of a randomized, 43-patient study at the American Urogynecologic Society annual scientific meeting
   ...
   "This was higher than previously reported in the literature," Dr. Brubaker said of the retention rate."Perhaps this was because we actually checked this in all patients, as opposed to seeing if they had the traditional symptoms of retention.One of the most important findings in the study is that you cannot rely on the typical clinical symptoms of retention-you must check."
   
   Dr. Brubaker defined retention as a post-void residual volume >200 mL regardless of symptoms at 4 weeks or catheterization.
   ...
   Dr. Brubaker is quick to note that this is still an off-label indication for botulinum toxin A, but high rates of efficacy in European case series of neurogenic patients, as well as reported clinical experience in idiopathic patients, helped plant the seeds for the trial.
   
   "The botulinum injection is less frequent than a daily pill, which enhances compliance and, therefore, probably enhances symptom control," Dr. Brubaker said.

3. 3. www.womenshealthexperience.com

   www.womenshealthexperience.com - [Cached]

   Published on: 5/17/2008   Last Visited: 5/17/2008

   Linda Brubaker, MDCo-Director, Women's Pelvic Medicine Center, Loyola University Medical Center; Professor or Obstetrics, Gynecology and Urogynecology, Loyola University Chicago Stritch School of Medicine